Robert Bwire is a seasoned medical professional with over 20 years of experience in the biopharmaceutical industry, specializing in drug safety, risk management, and clinical development. Currently serving as Vice President of Medical/Pharmacovigilance at SSI Strategy, Bwire supports biopharmaceutical companies in building effective pharmacovigilance teams while managing complex risk management programs. Previously, Bwire held significant roles at organizations such as Celgene and Organon NL, demonstrating a proven track record in overseeing safety teams across various therapeutic areas. Bwire is committed to the ethical development of novel medicines that enhance patient well-being.
This person is not in the org chart
This person is not in any teams
This person is not in any offices